Suven Pharmaceuticals Ltd Share Price (SUVENPHAR)
₹641.5
Suven Pharmaceuticals Ltd share Performance
- ₹635.15₹649₹641.5
0.99%
Low
Day's Volatility:2.16%
High
1.17%
- ₹468.6₹768₹641.5
26.95%
Low
52 Weeks Volatility:46.67%
High
19.72%
| Returns % | |
| 1 Month Return | 0.48 % |
| 3 Month Return | -5.79 % |
| 1 Year Return | 36.92 % |
| Market Stats | |
| Previous Close | ₹645.45 |
| Open | ₹645.45 |
| Volume | 47.79K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹16,430.90Cr |
Analyst Rating for Suven Pharmaceuticals Ltd stock
based on 2 analysts
Based on 2 analysts offering long term price targets for Suven Pharmaceuticals Ltd. An average target of ₹685.5
Source: S&P Global Market Intelligence
Company Information
Share Price: ₹641.50 per share as on 24 Apr, 2024 04:01 PM
Market Capitalisation: ₹16,430.90Cr as of today
Revenue: ₹219.82Cr as on December 2023 (Q4 23)
Net Profit: ₹46.75Cr as on December 2023 (Q4 23)
Listing date: 05 Mar, 2020
Chairperson Name: Annaswamy Vaidheesh
| Organisation | Suven Pharmaceuticals Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Suven Pharmaceuticals Ltd
Goldman Sachs India Buys 1.11% Stake in Suven Pharmaceuticals - 20 Apr, 2024
Goldman Sachs India has purchased a 1.11% stake in Suven Pharmaceuticals Ltd as of March 2024, with the company reporting revenue of Rs 220 crore and net profit of Rs 47 crore in Q3FY24.
Advent Looks to Take Advantage of China+1 Wave for Suven Pharma - 17 Apr, 2024
Private equity firm Advent, which merged Suven Pharma with Cohance Lifesciences in February, aims to leverage the China+1 wave and other geopolitical tailwinds. India's pharma outsourcing edge is limited by the scale of local contract manufacturers compared to global rivals from China and Europe.
Suven Pharma Underperforms Benchmark Indices - 15 Apr, 2024
Suven Pharmaceuticals has underperformed both the NSE Smallcap index and the Nifty Pharma index this year, shedding 13.5%. The company's sub-par earnings in Q3 2023 have contributed to its poor performance.
Fundamentals of Suven Pharmaceuticals Ltd
Insights on Suven Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 years, SUVENPHAR stock has moved up by 18.2%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 13.91% to 23.10% in Mar 2024 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 13.40% to 15.26% in Mar 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.9% return, outperforming this stock by 115.7%
- NO EFFECT
Against Peers
In the last 1 year, Sun Pharmaceuticals Industries Ltd has given 51.6% return, outperforming this stock by 14.7%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 10.14% to 9.54% in Mar 2024 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 60.00% to 50.10% in Mar 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, 123.97 Cr → 46.75 Cr (in ₹), with an average decrease of 26.0% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 380.76 Cr → 234.16 Cr (in ₹), with an average decrease of 14.2% per quarter
Suven Pharmaceuticals Ltd Valuation
Suven Pharmaceuticals Ltd in the last 5 years
Lowest (4.48x)
March 30, 2020
Today (44.27x)
April 23, 2024
Industry (61.41x)
April 23, 2024
Highest (51.50x)
January 4, 2024
Mutual Fund Holdings
| Funds | Holdings |
 UTI Flexi Cap Fund - Growth Option - Direct | 1.21% |
 DSP ELSS Tax Saver Fund Direct Plan Growth | 1.54% |
| DSP Healthcare Fund Direct Growth | 8.33% |
| DSP Equity Opportunities Fund Direct Plan Growth | 1.51% |
 HSBC Small Cap Fund Fund Direct Growth | 1.16% |
Shareholding Pattern
| Investors | Holdings % | Prev. 1 periods | 3M change |
|---|---|---|---|
| Promoter Holdings | 50.1% | 0.00 | |
| Foreign Institutions | 9.54% | 0.00 | |
| Mutual Funds | 15.26% | 0.00 | |
| Retail Investors | 23.1% | 0.00 | |
| Others | 1.99% | 0.00 |
Technicals of Suven Pharmaceuticals Ltd share
News & Events of Suven Pharmaceuticals Ltd
Frequently Asked Questions
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Suven Pharmaceuticals Ltd shares.
Suven Pharmaceuticals Ltd (SUVENPHAR) share price today is ₹641.5
Suven Pharmaceuticals Ltd is listed on NSE
Suven Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Suven Pharmaceuticals Ltd is ₹649.
- Today’s lowest price of Suven Pharmaceuticals Ltd is ₹635.15.
PE Ratio of Suven Pharmaceuticals Ltd is 44.27
PE ratio = Suven Pharmaceuticals Ltd Market price per share / Suven Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Suven Pharmaceuticals Ltd(SUVENPHAR) is 47.79K.
Today’s market capitalisation of Suven Pharmaceuticals Ltd(SUVENPHAR) is ₹16430.9Cr.
| Suven Pharmaceuticals Ltd(SUVENPHAR | Price |
|---|---|
52 Week High | ₹768 |
52 Week Low | ₹468.6 |
Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹641.5. It is down -16.47% from its 52 Week High price of ₹768
Suven Pharmaceuticals Ltd(SUVENPHAR) share price is ₹641.5. It is up 36.90% from its 52 Week Low price of ₹468.6
| Suven Pharmaceuticals Ltd(SUVENPHAR | Returns |
|---|---|
1 Day Returns | -3.95% |
1 Month Returns | 0.48% |
3 Month Returns | -5.79% |
1 Year Returns | 36.92% |